Purchase Order 75N91020P00908

<p>The National Cancer Institute awarded a purchase order to Creative Biolabs Inc. for $19,800.00 in lab testing services, effective September 16, 2020, with completion targeted for December 20, 2020. Work is performed in East Yaphank, New York under firm fixed-price terms. No small business set-aside applies to this order.</p>

The National Cancer Institute awarded a purchase order to Arraystar Inc. for $22,176.00 on June 14, 2021, for lab testing services. Work is performed in Rockville, Maryland. The order is firm fixed price with an ultimate completion date of July 14, 2021. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of...

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Creative Biolabs Inc. for antibody laboratory testing valued at $25,000, dated September 11, 2020, with completion by December 20, 2020. Work is performed at East Yaphank, New York under firm fixed-price terms. No set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $16,362.77 on February 26, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 31, 2020. The order procures sequencing-related services or equipment from Illumina's portfolio of genomic analysis technologies and associated support.</p>

<p>The National Cancer Institute awarded a purchase order to Cellomics Technology LLC for $17,110.00 on March 4, 2020. The order covers lab testing services. Work is performed in Halethorpe, Maryland. The order has a firm fixed price structure and an ultimate completion date of July 4, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

Adaptive Biotechnologies Corporation has been awarded a firm fixed price purchase order valued at thirteen thousand two hundred dollars from the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Adaptive will provide laboratory testing, adaptive immunosequencing, and DNA extraction services in support of unspecified NIH research programs. Performance will take place in Seattle, Washington through...

The Department of Health and Human Services (HHS) National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $61,150.00 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for SARS-COV-2 immunosequencing testing services. The contract has a performance period through September 30, 2024 and was awarded on May 7, 2024. Adaptive has previously provided specialized testing and genomic sequencing services to HHS,...